The Allstate Corporation (ALL) quarterly income statement — complete revenue, gross profit & net income history
| Revenue | 16.94B | 16.59B | 17.06B | 16.55B | 16.26B | 16.34B | 16.5B | 15.62B | 15.05B | 14.78B | 14.31B | 13.87B |
| Revenue Growth % | 4.17% | 1.52% | 3.42% | 5.9% | 8.05% | 10.6% | 15.26% | 12.63% | 10.43% | 9.95% | 10.68% | 14.94% |
| Medical Costs & Claims | 9.26B | 7.8B | 10.82B | 12.51B | 13.23B | 11.42B | 12.76B | 13.09B | 11.74B | 10.97B | 12.34B | 13.77B |
| Medical Cost Ratio % | 54.67% | 47.04% | 63.43% | 75.63% | 81.38% | 69.9% | 77.37% | 83.8% | 77.97% | 74.24% | 86.22% | 99.29% |
| Gross Profit | 7.68B | 8.79B | 6.24B | 4.03B | 3.03B | 4.92B | 3.73B | 2.53B | 3.32B | 3.81B | 1.97B | 98M |
| Gross Margin % | 45.33% | 52.96% | 36.57% | 24.37% | 18.62% | 30.1% | 22.63% | 16.2% | 22.03% | 25.76% | 13.78% | 0.71% |
| Gross Profit Growth % | 153.63% | 78.61% | 67.09% | 59.34% | -8.69% | 29.24% | 89.25% | 2482.65% | 156.06% | 163.21% | 113.53% | -88.03% |
| Operating Expenses | 4.47B | 3.87B | 1.42B | 1.33B | 2.31B | 2.47B | 2.32B | 2.1B | 1.85B | 1.98B | 1.99B | 1.85B |
| OpEx / Revenue % | 26.41% | 23.33% | 8.32% | 8.04% | 14.2% | 15.11% | 14.04% | 13.45% | 12.3% | 13.39% | 13.93% | 13.31% |
| Depreciation & Amortization | 47M | 108M | 115M | 127M | 132M | 151M | 140M | 132M | 132M | 165M | 176M | 186M |
| Combined Ratio % | 81.08% | 70.37% | 71.75% | 83.66% | 95.58% | 85.01% | 91.4% | 97.25% | 90.27% | 87.64% | 100.15% | 112.6% |
| Operating Income | 3.21B | 4.92B | 4.82B | 2.7B | 719M | 2.45B | 1.42B | 430M | 1.46B | 1.83B | -21M | -1.75B |
| Operating Margin % | 18.92% | 29.63% | 28.25% | 16.34% | 4.42% | 14.99% | 8.6% | 2.75% | 9.73% | 12.36% | -0.15% | -12.6% |
| Operating Income Growth % | 345.9% | 100.69% | 239.84% | 528.6% | -50.89% | 34.04% | 6852.38% | 124.6% | 460.59% | 535% | 97.69% | -33.33% |
| EBITDA | 3.25B | 5.02B | 4.93B | 2.83B | 851M | 2.6B | 1.56B | 562M | 1.6B | 1.99B | 155M | -1.56B |
| EBITDA Margin % | 19.2% | 30.28% | 28.92% | 17.1% | 5.23% | 15.91% | 9.44% | 3.6% | 10.6% | 13.48% | 1.08% | -11.26% |
| Interest Expense | 98M | 98M | 101M | 100M | 100M | 101M | 104M | 98M | 97M | 107M | 88M | 98M |
| Non-Operating Income | -27M | -98M | -101M | -100M | -100M | -101M | -104M | -98M | -97M | -107M | -88M | -98M |
| Pretax Income | 3.11B | 4.92B | 4.82B | 2.7B | 719M | 2.45B | 1.42B | 430M | 1.46B | 1.83B | -21M | -1.75B |
| Pretax Margin % | 18.35% | 29.63% | 28.25% | 16.34% | 4.42% | 14.99% | 8.6% | 2.75% | 9.73% | 12.36% | -0.15% | -12.6% |
| Income Tax | 650M | 1.09B | 1.07B | 604M | 123M | 559M | 254M | 83M | 266M | 340M | -17M | -373M |
| Effective Tax Rate % | 20.91% | 22.14% | 22.31% | 22.35% | 17.11% | 22.83% | 17.91% | 19.3% | 18.17% | 18.61% | 80.95% | 21.34% |
| Net Income | 2.46B | 3.83B | 3.75B | 2.11B | 595M | 1.93B | 1.19B | 331M | 1.22B | 1.49B | -5M | -1.35B |
| Net Margin % | 14.51% | 23.1% | 21.96% | 12.75% | 3.66% | 11.8% | 7.21% | 2.12% | 8.09% | 10.08% | -0.03% | -9.75% |
| Net Income Growth % | 313.11% | 98.76% | 214.79% | 537.16% | -51.15% | 29.48% | 23900% | 124.48% | 480.63% | 624.3% | 99.24% | -33.47% |
| EPS (Diluted) | 9.25 | 14.37 | 13.95 | 7.76 | 2.11 | 7.07 | 4.33 | 1.13 | 4.46 | 5.57 | -0.16 | -5.15 |
| EPS Growth % | 337.66% | 103.25% | 222.17% | 586.73% | -52.61% | 26.93% | 2864.86% | 121.94% | 465.57% | 584.35% | 93.86% | -37.7% |
| EPS (Basic) | 9.36 | 14.55 | 14.13 | 7.86 | 2.14 | 7.16 | 4.39 | 1.14 | 4.51 | 5.57 | -0.16 | -5.15 |
| Diluted Shares Outstanding | 262.6M | 264.7M | 266.4M | 267.9M | 267.8M | 268.7M | 268M | 267.1M | 266.5M | 264.7M | 261.8M | 262.6M |